CDK9-IN-7, CAS [[2369981-71-3]]

Produktübersicht

• Artikelname: CDK9-IN-7, CAS [[2369981-71-3]]
• Artikelnummer: MCE-HY-126251
• Hersteller Artikelnummer: HY-126251
• Alternativnummer: MCE-HY-126251-5MG,MCE-HY-126251-1MG,MCE-HY-126251-10MMX1ML,MCE-HY-126251-10MG,MCE-HY-126251-100MG,MCE-HY-126251-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

CDK9-IN-7 (compound 21e) is a selective, highly potent, and orally active CDK9/cyclin T inhibitor (IC50=11 nM), which exhibits more potent over other CDKs (CDK4/cyclinD=148 nM, CDK6/cyclinD=145 nM). CDK9-IN-7 shows antitumor activity without obvious toxicity. CDK9-IN-7 induces NSCLC cell apoptosis, arrests the cell cycle in the G2 phase, and suppresses the stemness properties of NSCLC[1].

Produkteigenschaften

• Molekulargewicht: 547.71
• Reinheit: 98.05
• CAS Nummer: [2369981-71-3]
• Formel: C29H37N7O2S
• Target-Kategorie: Apoptosis,CDK

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound